Mesoblast (MESO) Share-based Compensation (2018 - 2023)
Historic Share-based Compensation for Mesoblast (MESO) over the last 9 years, with Q2 2024 value amounting to $2.2 million.
- Mesoblast's Share-based Compensation rose 2492.89% to $2.2 million in Q2 2024 from the same period last year, while for Jun 2024 it was -$7.9 million, marking a year-over-year increase of 4804.11%. This contributed to the annual value of $2.2 million for FY2024, which is 2492.89% up from last year.
- Per Mesoblast's latest filing, its Share-based Compensation stood at $2.2 million for Q2 2024, which was up 2492.89% from $1.8 million recorded in Q2 2023.
- Mesoblast's Share-based Compensation's 5-year high stood at $8.4 million during Q4 2020, with a 5-year trough of -$12.1 million in Q3 2020.
- Moreover, its 5-year median value for Share-based Compensation was $1.1 million (2021), whereas its average is -$1.3 million.
- In the last 5 years, Mesoblast's Share-based Compensation skyrocketed by 24413.57% in 2020 and then tumbled by 57750.93% in 2022.
- Over the past 5 years, Mesoblast's Share-based Compensation (Quarter) stood at $8.4 million in 2020, then plummeted by 180.95% to -$6.8 million in 2021, then increased by 2.49% to -$6.6 million in 2022, then surged by 126.43% to $1.8 million in 2023, then increased by 24.93% to $2.2 million in 2024.
- Its Share-based Compensation was $2.2 million in Q2 2024, compared to $1.8 million in Q2 2023 and -$5.2 million in Q1 2023.